AYTU logo

Aytu BioPharma, Inc. (AYTU)

Profile

Full Name

Aytu BioPharma, Inc.

Ticker

NASDAQ: AYTU

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

United States

IPO

September 25, 2008

Indexes

Not included

Website

https://aytubio.com

Employees

102

Key Details

Price

$2.34(+0.43%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$81.00M(-24.58% YoY)

Annual EPS

-$2.86(+44.03% YoY)

PE ratio

-

Next earnings date

Sep 26, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.34
    AYTU price is $2.34

    30-Day Relative Volume

    5.26
    AYTU 30-day relative volume is 5.26

    Price Performance

    Price Most recent change

    +0.43%
    AYTU price was up +0.43% on Sep 16, 2025

    Price YTD change

    +37.65%
    AYTU price is up +37.65% since January 1st

    Price 1-year change

    -7.51%
    AYTU price is down -7.51% year-on-year

    Price 3-year change

    -44.29%
    AYTU price is down -44.29% over the past 3 years

    Price Range

    Price All-time high

    $11.82M
    AYTU price is currently -100.00% below its historical high of $11.82 million

    Price 3-year low

    $0.95
    AYTU price is currently +146.32% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $14.44M
    AYTU market capitalization is $14.44 million

    Market cap 3-year change

    +10.13%
    AYTU market capitalization is up +10.13% over the past 3 years

    Market cap All-time high

    $227.99M
    AYTU market capitalization is currently -93.67% below its historical high of $227.99 million

    Market cap sector rank

    18.96%
    AYTU market capitalization is higher than 18.96% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.34%
    AYTU shares outstanding is up +0.34% year-on-year

    Shares Outstanding 3-Year Change

    +97.66%
    AYTU shares outstanding is up +97.66% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.78
    AYTU beta is 0.78

    200-day SMA

    $1.74
    AYTU price is currently +34.83% above its 200-day simple moving average

    50-day SMA

    $2.35
    AYTU price is currently -0.22% below its 50-day simple moving average

    RSI

    53.35
    AYTU 14-day relative strength index is 53.35

    Volume

    5.26
    AYTU 30-day relative volume is 5.26

    ATR

    $0.14
    AYTU average true range is $0.14

    10-day Historical Volatility

    30.78%
    AYTU 10-day historical volatility is 30.78%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $81.00M
    AYTU annual revenue is $81.00 million

    Revenue Analysts estimate

    $69.15M
    AYTU annual revenue is currently +17.13% higher than the consensus analysts' forecast

    Revenue 1-year change

    -24.58%
    AYTU annual revenue is down -24.58% year-on-year

    Revenue Sector rank

    66.72%
    AYTU annual revenue is higher than 66.72% of companies in Healthcare sector

    EPS

    EPS

    -$2.86
    AYTU annual earnings per share is -$2.86

    EPS Analysts estimate

    $0.15
    AYTU annual earnings per share is currently -2006.67% lower than the consensus analysts' forecast

    EPS 1-year change

    +44.03%
    AYTU annual earnings per share is up +44.03% year-on-year

    EPS Sector rank

    30.48%
    AYTU annual earnings per share is higher than 30.48% of companies in Healthcare sector

    Profit

    Gross profit

    $49.37M
    AYTU annual gross profit is $49.37 million

    Gross margin

    60.95%
    AYTU annual gross profit margin is 60.95%

    Operating profit

    -$2.89M
    AYTU annual operating income is -$2.89 million

    Operating margin

    -3.57%
    AYTU annual operating profit margin is -3.57%

    Net income

    -$15.84M
    AYTU annual net profit is -$15.84 million

    Net margin

    -19.56%
    AYTU annual net profit margin is -19.56%

    Expenses

    Total expenses

    $96.85M
    AYTU annual total expenses is $96.85 million

    Operating expenses

    $52.26M
    AYTU annual total operating expenses is $52.26 million

    Cost of goods sold

    $31.63M
    AYTU annual cost of goods sold is $31.63 million

    Selling, general & administrative expenses

    $49.47M
    AYTU annual SGA is $49.47 million

    Depreciation and amortization

    $8.27M
    AYTU annual depreciation & amortization is $8.27 million

    Interest expense

    $0.00
    AYTU annual interest expense is $0.00

    Income tax

    $1.77M
    AYTU annual income tax is $1.77 million

    EBIT & EBITDA

    EBIT

    -$2.89M
    AYTU annual earnings before interest & taxes is -$2.89 million

    EBITDA

    $5.38M
    AYTU annual EBITDA is $5.38 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $118.86M
    AYTU annual total assets is $118.86 million

    Non current assets

    $56.20M
    AYTU annual long term assets is $56.20 million

    Current assets

    $61.89M
    AYTU annual total current assets is $61.89 million

    Cash and cash equivalents

    $20.01M
    AYTU annual cash & cash equivalents is $20.01 million

    Accounts receivable

    $23.62M
    AYTU annual accounts receivable is $23.62 million

    Inventory

    $12.63M
    AYTU annual inventory is $12.63 million

    Liabilities

    Total liabilities

    $91.14M
    AYTU annual total liabilities is $91.14 million

    Long term liabilities

    $17.46M
    AYTU annual total long term liabilities is $17.46 million

    Current liabilities

    $62.23M
    AYTU annual total current liabilities is $62.23 million

    Accounts payable

    $10.44M
    AYTU annual accounts payable is $10.44 million

    Debt

    Total debt

    $16.42M
    AYTU annual total debt is $16.42 million

    Total debt 1-year change

    -46.04%
    AYTU annual total debt is down -46.04% year-on-year

    Long term debt

    $11.45M
    AYTU annual long term debt is $11.45 million

    Short term debt

    $4.96M
    AYTU annual short term debt is $4.96 million

    Equity & Capital

    Shareholders equity

    $27.72M
    AYTU annual stockholders equity is $27.72 million

    Book value

    $27.72M
    AYTU annual book value is $27.72 million

    Retained earnings

    -$319.97M
    AYTU annual retained earnings is -$319.97 million

    Working capital

    -$337.00K
    AYTU annual working capital is -$337.00 thousand

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$1.39M
    AYTU annual cash flow from operations is -$1.39 million

    Cash from operations 1-year change

    +73.42%
    AYTU annual cash flow from operations is up +73.42% year-on-year

    Cash from investing

    -$329.00K
    AYTU annual cash flow from investing activities is -$329.00 thousand

    Cash from investing 1-year change

    -181.2%
    AYTU annual cash flow from investing activities is down -181.2% year-on-year

    Cash from financing

    -$1.26M
    AYTU annual cash flow from financing activities is -$1.26 million

    Cash from financing 1-year change

    -114.08%
    AYTU annual cash flow from financing activities is down -114.08% year-on-year

    CAPEX

    CAPEX

    $0.00
    AYTU annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    AYTU annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$1.39M
    AYTU annual free cash flow is -$1.39 million

    Free cash flow 1-year change

    +73.42%
    AYTU annual free cash flow is up +73.42% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    60.95%
    AYTU annual gross profit margin is 60.95%

    Operating margin

    -3.57%
    AYTU annual operating profit margin is -3.57%

    Net margin

    -19.56%
    AYTU annual net profit margin is -19.56%

    ROA & ROE

    ROA

    -12.34%
    AYTU annual return on assets is -12.34%

    ROE

    -47.24%
    AYTU annual return on equity is -47.24%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AYTU price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AYTU price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.41
    AYTU price to book ratio is 0.41

    PB ratio Sector rank

    23.13%
    AYTU price to book ratio is higher than 23.13% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.21
    AYTU price to sales ratio is 0.21

    PS ratio Sector rank

    6.31%
    AYTU price to sales ratio is higher than 6.31% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $18.79M
    AYTU enterprise value is $18.79 million

    Enterprise value Sector rank

    27.07%
    AYTU enterprise value is higher than 27.07% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    1.77
    AYTU EV/EBITDA is 1.77

    EV/EBITDA Sector rank

    74.98%
    AYTU EV/EBITDA is higher than 74.98% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.99
    AYTU annual current ratio is 0.99

    Quick ratio

    0.79
    AYTU annual quick ratio is 0.79

    Leverage

    Debt to equity

    0.59
    AYTU annual debt to equity ratio is 0.59

    Interest coverage ratio

    -
    AYTU annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    AYTU piotroski f-score is 3

    Altman Z-Score

    -3.08
    AYTU altman z-score is -3.08

    Analyst ratings

    Recent major analysts updates

    Jul 1, 25 Lake Street
    Buy
    Jun 30, 25 Ascendiant Capital
    Buy
    Aug 9, 23 Maxim Group
    Buy
    May 31, 23 HC Wainwright & Co.
    Buy
    Jul 21, 22 HC Wainwright & Co.
    Buy
    May 17, 22 Cantor Fitzgerald
    Overweight
    Apr 28, 22 HC Wainwright & Co.
    Buy
    Mar 30, 21 Cantor Fitzgerald
    Overweight
    Nov 25, 20 Northland Securities
    Outperform
    Nov 25, 20 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with AYTU included

    Growing Shares Outstanding
    US stocks
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Best performing stocks YTD
    • What is the ticker symbol for Aytu BioPharma, Inc.?
    • Does Aytu BioPharma, Inc. pay dividends?
    • What sector is Aytu BioPharma, Inc. in?
    • What industry is Aytu BioPharma, Inc. in?
    • What country is Aytu BioPharma, Inc. based in?
    • When did Aytu BioPharma, Inc. go public?
    • Is Aytu BioPharma, Inc. in the S&P 500?
    • Is Aytu BioPharma, Inc. in the NASDAQ 100?
    • Is Aytu BioPharma, Inc. in the Dow Jones?
    • When was Aytu BioPharma, Inc.'s last earnings report?
    • When does Aytu BioPharma, Inc. report earnings?

    What is the ticker symbol for Aytu BioPharma, Inc.?

    The ticker symbol for Aytu BioPharma, Inc. is NASDAQ:AYTU

    Does Aytu BioPharma, Inc. pay dividends?

    No, Aytu BioPharma, Inc. does not pay dividends

    What sector is Aytu BioPharma, Inc. in?

    Aytu BioPharma, Inc. is in the Healthcare sector

    What industry is Aytu BioPharma, Inc. in?

    Aytu BioPharma, Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is Aytu BioPharma, Inc. based in?

    Aytu BioPharma, Inc. is headquartered in United States

    When did Aytu BioPharma, Inc. go public?

    Aytu BioPharma, Inc.'s initial public offering (IPO) was on September 25, 2008

    Is Aytu BioPharma, Inc. in the S&P 500?

    No, Aytu BioPharma, Inc. is not included in the S&P 500 index

    Is Aytu BioPharma, Inc. in the NASDAQ 100?

    No, Aytu BioPharma, Inc. is not included in the NASDAQ 100 index

    Is Aytu BioPharma, Inc. in the Dow Jones?

    No, Aytu BioPharma, Inc. is not included in the Dow Jones index

    When was Aytu BioPharma, Inc.'s last earnings report?

    Aytu BioPharma, Inc.'s most recent earnings report was on May 14, 2025

    When does Aytu BioPharma, Inc. report earnings?

    The next expected earnings date for Aytu BioPharma, Inc. is September 26, 2025
    On this page